Organisation
Department of Pharmaceutics
Department
Projects
241 - 250 of 375
- ICONS: Innovation in pharmaceutical manufacturing of oral solid dosage forms via continuous processingFrom1 Jan 2016 → 30 Jun 2018Funding: IWT / VLAIO - indirect funding by business world
- Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to BedsideFrom1 Jan 2016 → 9 Oct 2021
- An eco-evolutionary network of biotic interactionsFrom1 Jan 2016 → 31 Dec 2020Funding: FWO scientific research network
- OVDS Sean Mc Cafferty: Drug-controllable protein expression forOVOS Sean Mc Cafferty: Drug-controllable protein expression form IL-12 encoding modified mRNA.From1 Jan 2016 → 31 Dec 2016Funding: FWO Humanitarian research project Stand up against Cancer
- Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to BedsideFrom1 Jan 2016 → 9 Oct 2021Funding: BOF - Concerted Research Project from 1994
- Screening for molecular adjuvants to enhance cytoplasmic delivery of
small interfering RNA in cancer cellsFrom1 Jan 2016 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Dynamic polymeric systems as basis for reusable high performance materials and polymer therapeuticsFrom1 Jan 2016 → 31 Oct 2021Funding: BOF - Concerted Research Project from 1994
- Nanomedicine: an integrative approachFrom1 Jan 2016 → 31 Dec 2019Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
- Nanobody-based depletion or reprogramming of protumoral tumor-associated macrophages for the enhancement of therapy responseFrom15 Nov 2015 → 14 Nov 2019Funding: FWO Humanitarian research project Stand up against Cancer
- Exploring ultrasound mediated mRNA transfection of lymph nodes and ultrasound-induced tumor ablation as a synergistic anticancer strategy.From1 Oct 2015 → 30 Sep 2019Funding: FWO fellowships
Publications
1 - 10 of 1928
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists(2008)
Authors: HJ Ko, RL Carter, Liesbet Cosyn, R Petrelli, S de Castro, P Besada, YX Zhou, L Cappellacci, P Franchetti, M Grifantini, et al.
Pages: 6319 - 6332 - Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity(2009)
Authors: Jan Balzarini, Ineke Van Daele, Ana Negri, Nicola Solaroli, Anna Karlsson, Sandra Liekens, Frederico Gago, Serge Van Calenbergh
Pages: 1127 - 1136 - ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in review(2015)
Authors: Guy Brusselle, Mina Gaga
Pages: 863 - 866 - Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status(2012)
Authors: Guy Brusselle, Rudi Peché, Paul Van den Brande, Albert Verhulst, Wim Hollanders, Jacques Bruhwyler
Pages: 811 - 819 - Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns(2014)
Authors: David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, et al.
Pages: 889 - 905 - Integrating real-life studies in the global therapeutic research framework(2013)
Authors: Nicolas Roche, Helen K Reddel, Alvar Agusti, Eric D Bateman, Jerry A Krishnan, Richard J Martin, Alberto Papi, Dirkje Postma, Mike Thomas, Guy Brusselle, et al.
Pages: e29 - e30 - The significance of eosinophilic inflammation in chronic obstructive pulmonary disease(2018)
Authors: Christopher B Cooper, Guy Brusselle, Steven J Pascoe, Ian D Pavord
Pages: 967 - 968 - InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol(2013)
Authors: Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth
- Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example(2015)
Authors: Guy Brusselle, Francesco Blasi
Pages: 109 - 110 - Exacerbation rate reduction according to baseline blood eosinophilic count in patients with asthma treated with ICS/LABA maintenance and reliever therapy(2019)Volume: 199
Authors: Guy Brusselle, A Papi, G Nicolini, L Santoro, D Guastalla
Number of pages: 1